SARS-CoV-2 monoclonal antibody (CB6 biosimilar)
Applications | ELISA, FC |
Reactivities | SARS-CoV-2 |
SARS-CoV-2 monoclonal antibody (CB6 biosimilar)
Applications | ELISA, FC |
Reactivities | SARS-CoV-2 |
SARS-CoV monoclonal antibody (CR3022 biosimilar)
Applications | ELISA, FC |
Reactivities | SARS-CoV-2 |
Chikungunya virus human monoclonal antibody, clone E26D9
Applications | IF, Neutralize |
Reactivities | Human |
Chikungunya virus human monoclonal antibody, clone E26D9
Applications | IF, Neutralize |
Reactivities | Human |
Recombinant Anti-CD11a (Clone hu1124 (Efalizumab))
Applications | Bl, FC |
Reactivities | Human |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
Applications | ELISA, FC |
Reactivities | Human |
Anti-NKp46 [Bab281], Human IgG1, kappa
Applications | FC, IF, IP |
Reactivities | Human, Macaque |
Modifications | This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques. |
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
Applications | ELISA, FC, IHC |
Reactivities | Human |
Recombinant Anti-Phl p 1 (Clone Clone 25)
Applications | Dot, ELISA, WB |
Reactivities | Rat |
Recombinant Anti-ED-B domain of fibronectin (Clone A2)
Applications | ELISA, IHC, WB |
Reactivities | Human |
Recombinant Anti-ED-B domain of fibronectin (Clone G4)
Applications | ELISA, IHC, WB |
Reactivities | Human |
Recombinant Anti-EGFR domain III (Clone h-R3 (Nimotuzumab))
Applications | Bl, FC, IHC |
Reactivities | Human |
Recombinant Anti-CD22 (Clone hL22 (Epratuzumab))
Applications | Bl, FC, IP |
Reactivities | Human, Monkey |
Recombinant Anti-EGFR (Clone 2F8 (Zalutumumab; HuMax-EGFR))
Applications | ELISA, FC, WB |
Reactivities | Human |
Anti-IL-8 [WS-4], Human IgG1, kappa
Applications | ELISA, IHC, Neutralize |
Reactivities | Human, Rabbit |